PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.\', \'Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy; Laboratory of Experimental Neurosciences, Ospedale Policlinico San Martino IRCCS, Genoa, Italy.\', \'Ospedale Policlinico San Martino IRCCS, Genoa, Italy.\', \'Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy; Ospedale Policlinico San Martino IRCCS, Genoa, Italy.\', \'Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy; Ospedale Policlinico San Martino IRCCS, Genoa, Italy. Electronic address: m.inglese@unige.it.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0022-510X(21)00195-710.1016/j.jns.2021.117501
?:hasPublicationType
?:journal
  • Journal of the neurological sciences
is ?:pmid of
?:pmid
?:pmid
  • 34044238
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.002
?:rankingScore_hIndex
  • 120
is ?:relation_isRelatedTo_publication of
?:title
  • Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic?
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all